Catriona Jamieson, MD, PhD
Disclosures: Co-founder -Ended January 2018- Acquired by Celgene-Impact Biomedicines Inc|Co-founder-Current-Wintherix Inc|Patent Royalties-Current-Forty Seven Inc|Unrestricted Research grant-Current-Johnson and Johnson|Unrestricted Research grant-Current-Celgene
No Bio Available.